245 related articles for article (PubMed ID: 22435424)
1. Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis.
Patel LM; Maghari A; Schwartz RA; Kapila R; Morgan AJ; Lambert WC
Int J Dermatol; 2012 Apr; 51(4):383-8. PubMed ID: 22435424
[TBL] [Abstract][Full Text] [Related]
2. Leukemic vasculitis: an unusual manifestation of leukemia cutis.
Seckin D; Senol A; Gurbuz O; Demirkesen C
J Am Acad Dermatol; 2009 Sep; 61(3):519-21. PubMed ID: 19481293
[TBL] [Abstract][Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. Aleukemic Myeloid Leukemia Cutis with a Kikuchi Disease-Like Inflammatory Pattern in Myelodysplastic Syndrome.
Khieu M; Beauvais A; Matz R; Bersabe A; Brown P; Brown A; Fillman E; Hall J
South Med J; 2017 Apr; 110(4):308-313. PubMed ID: 28376531
[TBL] [Abstract][Full Text] [Related]
5. [Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].
Jennane S; Eddou H; Mahtat el M; Konopacki J; Souleau B; Malfuson JV; Foissaud V; de Revel T
Ann Biol Clin (Paris); 2013; 71(5):581-4. PubMed ID: 24113443
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome.
Farah C; Bulai Livideanu C; Jegu J; Paul C; Viraben R; Lamant L; Delavigne K; Adoue D; Laurent G; Beyne Rauzy O
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1171-5. PubMed ID: 20202054
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous leukaemic infiltrations in a patient with previously undiagnosed myelodysplastic syndrome.
Schneider LA; Weber L; Viardot A; Schubert R; Hinrichs R; Scharffetter-Kochanek K
Clin Exp Dermatol; 2004 Sep; 29(5):468-70. PubMed ID: 15347325
[TBL] [Abstract][Full Text] [Related]
8. Disseminated cutaneous granulomatous eruption occurring in the setting of myelodysplasia.
Katz KA
Dermatol Online J; 2003 Oct; 9(4):22. PubMed ID: 14594595
[TBL] [Abstract][Full Text] [Related]
9. [Factors influencing leukemic transformation in myelodysplastic syndrome].
Borbényi Z; Varga G; Bérczi M; Gurzó M
Orv Hetil; 1990 Jun; 131(23):1231-6, 1239-40. PubMed ID: 2199892
[TBL] [Abstract][Full Text] [Related]
10. Leukemia cutis in acute myeloid leukemia signifies a poor prognosis.
Krooks JA; Weatherall AG
Cutis; 2018 Oct; 102(4):266;271;272. PubMed ID: 30489552
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature.
Chan MP; Duncan LM; Nazarian RM
J Am Acad Dermatol; 2013 Jun; 68(6):1006-15. PubMed ID: 23399459
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic phenomena as the first sign of myelodysplastic syndrome].
van Rijn RS; Wittebol S; Graafland AD; Kramer MH
Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1529-33. PubMed ID: 11525083
[TBL] [Abstract][Full Text] [Related]
13. Aleukemic leukemia cutis. An unusual presentation of acute myelomonocytic leukemia.
De Coninck A; De Hou MF; Peters O; Van Camp B; Roseeuw DI
Dermatologica; 1986; 172(5):272-5. PubMed ID: 2943614
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.
Bresolin S; Trentin L; Zecca M; Giordan M; Sainati L; Locatelli F; Basso G; te Kronnie G
Leukemia; 2012 Jul; 26(7):1717-9. PubMed ID: 22411123
[No Abstract] [Full Text] [Related]
15. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
[TBL] [Abstract][Full Text] [Related]
16. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
17. Utility of myeloperoxidase stain in the differential diagnosis of leukemia cutis vs. hystiocitoid Sweet syndrome.
Valerón-Almazán P; Bastida J; Vilar J; Santana N; Medina C; Carretero G
Dermatol Online J; 2011 Apr; 17(4):11. PubMed ID: 21549086
[TBL] [Abstract][Full Text] [Related]
18. Cytophagic and S-100 protein immunoreactive myeloid leukemia cutis.
Thomas CG; Patel RM; Bergfeld WF
J Cutan Pathol; 2010 Mar; 37(3):390-5. PubMed ID: 19615019
[TBL] [Abstract][Full Text] [Related]
19. Leukemia cutis from CD56 positive, myeloperoxidase negative acute myeloid leukemia.
Abdou AG; Seleit I; Bakry OA; Abdel-Wahed MM
Acta Dermatovenerol Croat; 2013; 21(3):189-92. PubMed ID: 24183224
[TBL] [Abstract][Full Text] [Related]
20. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
